Though Johnson & Johnson recently received authorization to distribute its single-dose COVID-19 vaccine, the majority of vaccinated people in the US have received either the Pfizer or Moderna vaccines at this point in time. Both latter vaccines require two doses, which raised concerns that many people may not return for the second dose. On Monday, the Centers for Disease Control …